COMMUNIQUÉS West-GlobeNewswire

-
TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma
21/12/2018 -
Novo Nordisk A/S: Share repurchase programme
21/12/2018 -
RECORDATI ACQUIRES TONIPHARM S.A.S. IN FRANCE
21/12/2018 -
Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018 -
CTD Holdings Closes $2.0 Million Private Placement
21/12/2018 -
Entry into a Material Definitive Agreement
21/12/2018 -
Project HOPE Deploys Medical Team to Colombian Border Towns to Ease Suffering of Venezuelans
21/12/2018 -
Abattis Provides Marketing and Operational Updates
21/12/2018 -
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
21/12/2018 -
Nemaura Announces Completion of Key Stages of Technical File Review for SugarBEAT® CE Mark Approval
21/12/2018 -
United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSpring’s Lead Asset Plinabulin with Protection to 2036
21/12/2018 -
Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019
21/12/2018 -
Surface Oncology Added to the NASDAQ Biotechnology Index
21/12/2018 -
Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
21/12/2018 -
Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan
21/12/2018 -
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
21/12/2018 -
Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305
21/12/2018 -
Holding(s) in Company
21/12/2018 -
ViroGates financial calendar 2019
21/12/2018
Pages